Pfizer, BYU Settle Celebrex Lawsuit for $450 Million

One month from the scheduled beginning of a complex eight-week trial, Brigham Young University and drug giant Pfizer settled a lawsuit for $450 million over whether the Utah school had been cheated out of billions of dollars in royalties for aiding in the development of the wildly successful anti-pain drug Celebrex.
The Salt Lake Tribune